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Objective: To assess the oncological and functional outcomes of T1b squamous cell carcinoma (SCC) of the glottic
larynx treated with laser in comparison with radiation.
Design: A Canadian multicenter cohort study.
Setting: Three tertiary referral centers for head and neck cancer- Dalhousie University in Halifax, Nova Scotia,
Western University in London, Ontario and the University of Manitoba, Winnipeg.
Methods: Patients with T1b glottic SCC who underwent transoral laser resection or radiation as the primary
modality of treatment.
Outcome measures: Oncological outcomes were evaluated using local control, laryngeal preservation, disease free
survival and disease specific survival. Voice outcomes were assessed using the Voice Handicap Index-10 (VHI-10).
Results: 63 patients met study criteria. 21 were treated with laser and 42 with radiation. Oncologic outcomes at
2 years for laser and radiation demonstrated local control of 95% and 85.9%; laryngeal preservation of 100% and
85.9%; disease free survival of 88.7% and 85.9% and overall survival of 94.1% and 94.8% respectively. VHI-10 data
was available for 23/63 patients. During the last follow up visit VHI-10 ranged from 0 to 11 (median 6) in the laser
group and 0 to 34 (median 7) in the radiation group.
Conclusion: T1b SCC of the glottis can be effectively treated with transoral laser microsurgery with oncological
outcomes that are at least equivalent to radiation. For patients with VHI scores, voice quality was similar between
the two groups. To our knowledge this is the first study directly comparing the oncologic and voice outcomes with
laser and radiation for the treatment of glottic cancer involving the anterior commissure.
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The last decade has seen a significant change in the
management of laryngeal cancer. In the past, early laryn-
geal cancers have traditionally been treated with radi-
ation or open partial laryngeal surgery. Transoral laser
microsurgery for early stage glottic cancer was originally
described by Strong and Jako in 1972 [1]. This was fur-
ther popularized by Steiner [2]. With the knowledge* Correspondence: smtaylorwashu@yahoo.com
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for the management of locally advanced laryngeal cancer
[3]. The popularity of laser surgery has also resulted in a
significant decline in open partial surgery.
Anterior commissure involvement is seen in about
20% of all glottic tumours and is generally associated
with worse outcomes [4]. Some consider Broyle’s liga-
ment as a barrier for tumour spread while other con-
sider this as an easy access for tumour to spread to the
thyroid cartilage [5-7]. Many believe that voice outcome
after resection of the anterior commissure with laser is
worse than treating with radiation. There is no conclu-
sive evidence on the superiority of voice outcomes with
either treatment and the current literature reports mixed
results. Uncertainty regarding the voice outcomes andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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missure are factors that prevent some surgeons from
attempting laser resection of these lesions. In our study,
we assessed the oncological and voice outcomes after
laser resection and radiation of tumours involving this
very complex area.
Materials and methods
All patients with primary T1bN0M0 squamous cell car-
cinoma of the glottis presenting to three tertiary referral
centres in Canada from 2002 to 2010 were included in
the study. Patients were staged using endoscopy (flexible
or rigid) and, in some instances scanning (MRI/CT). Re-
current tumours and tumours that were not staged at
T1b were excluded from the present analysis. All pa-
tients were presented at the multidisciplinary tumour
board at their respective institutions. In all the three
centers the tumour board recommendation and the op-
tions of treatment with surgery and radiation were
discussed with the patient by the surgical oncologist and
radiation oncologist. After meeting with both specialists,
patients chose their treatment modality based on per-
sonal preferences and tumour board recommendation.
Oncological and functional outcomes data were pro-
spectively collected by each center independently. Ap-
proval for data collection was obtained in advance by
each institutional research ethics board. Oncological
outcome measures used were local control, laryngeal
preservation, disease free survival and overall survival.
Voice outcomes were measured using the voice handi-
cap index-10 (VHI-10). VHI-10 data was not originally
collected at every center, and collection was standardized
midway through the study. Table 1 shows the VHI-10
scoring sheet.
A descriptive analysis of demographics, morbidities,
outcomes and VHI-10 data was performed. SPSS versionTable 1 VHI-10 score
F 1. My voice makes it difficult for people to hear me. 0 1 2 3 4
P 2. I run out of air when I talk. 0 1 2 3 4
F 3. People have difficulty understanding me in a
noisy room.
0 1 2 3 4
P 4. The sound of my voice varies throughout the day. 0 1 2 3 4
F 5. My family has difficulty hearing me when I call
them throughout the house.
0 1 2 3 4
F 6. I use the phone less often than I would like to. 0 1 2 3 4
E 7. I’m tense when talking to others because of
my voice.
0 1 2 3 4
F 8. I tend to avoid groups of people because of
my voice.
0 1 2 3 4
E 9. People seem irritated with my voice. 0 1 2 3 4
P 10. People ask, “What’s wrong with your voice?” 0 1 2 3 4
0 = never, 1 = almost never, 2 = sometimes, 3 = almost always, 4 = always.17 was used for the analysis. Student’s t-test was used to
analyse continuous, normally distributed variables and
Fisher’s exact test was used to analyse nominal variables.
All statistical testing was performed using an intention
to treat analysis unless otherwise stated in the results.
Kaplan Meier 24-month survival analyses were per-
formed for: local control, disease free survival, laryngeal
preservation, and overall survival. An event for local
control was defined as a local recurrence obtained after
TLM. Disease free survival was defined as either local or
regional recurrence or the presence of a second glottic
primary. Cancers were defined as a second primary if
they occurred greater than 5 years after the last received
treatment modality, or if they occurred on the contralat-
eral side to a previously treated unilateral tumour that
not cross midline and did not involve the anterior
commissure.Results
A total of 63 patients were included in the study. Of
these, 21 patients underwent laser resection and 42 pa-
tients received radiation. All patients in the radiation
arm were treated with a planned curative dose of radi-
ation. Follow up ranged from 5 to 102 months (median
34 in both laser and RT groups). Of the 63 patients in-
cluded in the study, there were 57 males and 6 females.
See Table 2 for demographic information.
Three patients in the laser group developed complica-
tions. One patient developed a vocal cord granuloma
that was managed conservatively and after 6 years his
VHI score was 5. This patient is currently singing in a
traditional music group and is pleased with their post-
operative voice. Another patient developed an anterior
glottic web and underwent division of the web and inser-
tion of a laryngeal keel. This patient’s VHI score was 21
prior to the reconstructive surgery but was reduced to
10 at the time of his last visit.
No patients in the laser group required a tracheostomy.
One patient developed respiratory distress after surgery
and had to be re-intubated. He was successfully extubated
after 24 hours in ICU. There were two complications in
the radiotherapy group. One patient developed significant
chondronecrosis and required a functional total laryngec-
tomy. A second patient required a tracheostomy due to
airway compromise.Table 2 Demographic information
Variable TLM Radiation p
Age (mean) 64.3 68.6 0.15
Gender (male/female) 18/3 39/3 0.39
Follow up (months - mean) 35.6 35.4 0.96
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Figures 1, 2, 3 and 4 Kaplan Meier plots for the local
control, laryngeal preservation, disease free survival and
overall survival. Two patients recurred in the laser arm
at 6 and 23 months respectively. The patient who re-
curred after 6 months had aggressive disease when the
recurrence was diagnosed. The recurrence was in the
contralateral vocal cord (cord with minimal disease at
the time of the primary treatment) with metastatic neck
nodes in the ipsilateral side. This was salvaged with neck
dissection, further laser treatment and post-operative
chemoradiation. The patient who recurred at 23 months
developed regional neck node metastasis in the pretra-
cheal and supraclavicular nodes and distant pulmonary
metastasis but no local recurrence. This patient under-
went treatment with palliative intent and died 37 months
after the primary treatment. One patient died due to
causes unrelated to the tumour. The two-year survival
rates are as follows: local control rate of 95%, laryngeal
preservation rate of 100% disease free survival of 88.7%
and overall survival of 94.1%.
Five patients in the radiation group developed local re-
currence at 6, 7, 8, 15 and 21 months after the primary
treatment. Four patients underwent salvage total laryn-
gectomy of which one patient died of peristomal re-
currence. One patient was salvaged with open partial
laryngectomy. A single patient died due to tumour while
3 patients died due to factors not related to their laryn-
geal carcinoma. The two-year survival rates are as fol-
lows: local control rate of 85.9%, laryngeal preservationFigure 1 Local control.rate of 85.9%, disease free survival of 85.9%, and overall
survival of 94.8%.
Voice outcomes
VHI-10 data was available for 13 patients in radiation
group and 10 patients in laser group. During the last
work up VHI-10 ranged from 0 to 11 (median 6) in the
laser group and 0 to 34 (median 7) in the radiation
group. In the radiation group one patient had a trache-
ostomy (VHI-10 of 34), which resulted in a wider range
of VHI score.
Discussion
Staging of the involvement of anterior commissure is
controversial. Steiner has further classified T1a, T1b and
T2a, as with or without anterior commissure involve-
ment [8]. There is no international consensus on the
management of tumours involving the anterior commis-
sure. Certain countries have issued guidelines for the
management of tumours involving the anterior commis-
sure. Dutch national guidelines recommend performing
laser surgery only on T1a lesions when a sufficient mar-
gin can be obtained within the affected fold. They fur-
ther recommend this using either a subligamental or
subepithelial resection that does not extend into the an-
terior commissure. Lesions that require resection of the
anterior commissure have in the past largely been
regarded as unsuitable for laser surgery because of poor
voice quality [9]. According to the consensus statement
on management in the United Kingdom, patients should
Figure 2 Laryngeal preservation.
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anterior commissure, but advised of the greater chance
of adverse voice outcome when the anterior commissure
is treated surgically [10]. Steiner and colleagues reported
that laser surgery is effective despite anterior commis-
sure involvement [11].Figure 3 Disease free survival.Disadvantages of laser surgery include: the need for
general anaesthesia, difficult access to anterior commis-
sure, and possibly poor voice outcome due to resection
of anterior commissure. By comparison the disadvan-
tages of radiotherapy include: longer treatment schedule,
increased expense, risk of chondronecrosis, development
Figure 4 Overall survival.
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rence due to oedema, and total laryngectomy is often re-
quired as a salvage operation [12].
Oncological outcomes
According to some studies, anterior commissure involve-
ment adversely affects local control, laryngeal preservation
and survival [13-15]. Other studies have not found this ef-
fect to be significant [16,17]. Mlynarek compared patients
with early glottic cancer after radiotherapy and microsur-
gery and found that in both groups 50% of patients with
involvement of anterior commissure had recurrences [18].
Opinion is divided regarding the effectiveness of radio-
therapy for local control of tumours involving the anter-
ior commissure. Five-year control rates for tumours with
involvement of the anterior commissure varied from
56% to 80% and without anterior commissure involve-
ment from 82% to 90% [13,14,19,20]. In contrast a study
by Mendenhall showed no difference in local control
rate [21]. Sjogren studied 36 patients with anterior com-
missure involvement who had radiotherapy as their pri-
mary treatment. Five patients developed local recurrence
and 1 patient developed distant metastasis. Three pa-
tients underwent total laryngectomy as salvage. Their
local control and laryngeal preservation rates were 88%
and 91% respectively [9].
Steiner and colleagues studied 89 T1 glottic cancer pa-
tients with anterior commissure involvement and reported
21 local recurrences. Their 5 year local control, laryngeal
preservation rate, ultimate local control and overall survivalwere 71%, 95%, 98% and 88% respectively [8]. In a larger
series by Motta (169 patients with anterior commissure in-
volvement) actuarial survival, adjusted actuarial survival
and ultimate local control were 84%, 96% and 83% re-
spectively [22]. Gallo studied 22 patients with anterior
commissure involvement and local control and overall
survival were 91% and 95% respectively [23]. In the paper
by Bocciolini 5 out of 10 patients developed local recur-
rence and their laryngeal preservation rate was 80%.
In our study there was an apparent difference in the
local control and laryngeal preservation rates between
the laser and radiation arms as seen from the Kaplan
Meier plots. These observed differences would be clinic-
ally significant, but are not statistically significant in the
present study (p = 0.38 for local control and 0.077 for la-
ryngeal preservation using the Log Rank test). In the
present study, the lack of significance likely represents
our small sample size rather than no true effect. Disease
free survival and overall survival shows no significant
differences between modalities (p = 0.82 and 0.6 respect-
ively using the Log Rank test).
Voice outcomes
Cohen in 2006 performed a meta-analysis from 1966 to
2005 comparing voice outcomes with radiation com-
pared with laser for the treatment of early glottic cancer.
This series included 6 studies with 208 patient (6 T1b
and 202 T1a) treated with laser and 91 patients (6T1b
and 85 T1a) treated with radiation. This showed com-
parable levels of voice handicap with both interventions.
Taylor et al. Journal of Otolaryngology - Head and Neck Surgery 2013, 42:22 Page 6 of 7
http://www.journalotohns.com/content/42/1/22This study reported that the resections involving the
superficial vocalis muscle (mean VHI, 6.23) had improved
VHI scores compared to those involving the contralateral
vocal fold (mean VHI, 15.7) and concluded that further
study is needed to clarify voice outcomes in lesions involv-
ing anterior commissure [24]. Our study shows no obvious
difference in the post-operative VHI-10 score between the
two arms.
To our knowledge there are no studies in the literature
directly comparing the oncologic and voice outcomes
for the treatment of glottic cancer with anterior commis-
sure involvement after treatment with laser and radi-
ation. Access to the anterior commissure is one of the
determining factors when assessing the feasibility for
laser resection. We generally use Kleinsasser laryngo-
scope to expose the larynx. In our experience we were
able to successfully complete the procedure in all the pa-
tients listed for laser resection in the T1b cohort.
Limitations of the study
Due to lack of randomization study design the possibility
of selection bias is unavoidable. Given that all tumours
were a narrowly defined T-stage and demographic infor-
mation was similar between groups, we do not believe
that this bias is so significant that it negates our ability
to make meaningful comparisons between groups.
A further weakness of the study was the lack universal
VHI-10 data. Finally, lack of intra-operative staging in
the radiation arm could have potentially under staged
some cancers. Interestingly none of the patients in the
laser arm were up staged intra-operatively.
Conclusion
In our experience stage T1b squamous cell carcinoma of
the glottis can be effectively treated with transoral laser
microsurgery with oncological outcomes that appear to
be superior when compared to primary radiation. Post-
therapy voice quality, which has been a major consider-
ation in the selection of treatment modality, was similar
in both groups. To our knowledge this is the first study
directly comparing the oncologic and voice outcomes
with laser and radiation for the treatment of glottic can-
cer involving the anterior commissure.
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